- Home
- ALGS vs CLST Comparison
ALGS vs CLST Comparison
Compare ALGS & CLST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALGS
- CLST
- Stock Information
- Founded
- ALGS 2018
- CLST 1922
- Country
- ALGS United States
- CLST United States
- Employees
- ALGS N/A
- CLST N/A
- Industry
- ALGS Biotechnology: Pharmaceutical Preparations
- CLST
- Sector
- ALGS Health Care
- CLST
- Exchange
- ALGS Nasdaq
- CLST Nasdaq
- Market Cap
- ALGS 64.8M
- CLST 54.6M
- IPO Year
- ALGS 2020
- CLST N/A
- Fundamental
- Price
- ALGS $7.21
- CLST $14.39
- Analyst Decision
- ALGS Strong Buy
- CLST
- Analyst Count
- ALGS 2
- CLST 0
- Target Price
- ALGS $60.00
- CLST N/A
- AVG Volume (30 Days)
- ALGS 99.6K
- CLST 10.5K
- Earning Date
- ALGS 11-06-2025
- CLST 10-23-2025
- Dividend Yield
- ALGS N/A
- CLST N/A
- EPS Growth
- ALGS N/A
- CLST N/A
- EPS
- ALGS N/A
- CLST 0.60
- Revenue
- ALGS $3,174,000.00
- CLST $11,340,000.00
- Revenue This Year
- ALGS N/A
- CLST N/A
- Revenue Next Year
- ALGS N/A
- CLST N/A
- P/E Ratio
- ALGS N/A
- CLST $23.90
- Revenue Growth
- ALGS N/A
- CLST 133.67
- 52 Week Low
- ALGS $3.76
- CLST $10.67
- 52 Week High
- ALGS $46.80
- CLST $15.30
- Technical
- Relative Strength Index (RSI)
- ALGS 28.33
- CLST 89.53
- Support Level
- ALGS $9.25
- CLST $13.65
- Resistance Level
- ALGS $8.76
- CLST $15.30
- Average True Range (ATR)
- ALGS 0.77
- CLST 0.30
- MACD
- ALGS -0.30
- CLST 0.13
- Stochastic Oscillator
- ALGS 2.68
- CLST 75.49
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
About CLST Catalyst Bancorp Inc.
Catalyst Bancorp Inc is a bank holding company. Through its subsidiary, which is a federally chartered community-oriented savings bank, it is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources, which are used for the origination of loans. It derives income principally from interest earned on loans and investment securities and, to a lesser extent, from fees received in connection with the origination of loans, service charges on deposit accounts, and other services.